EP3475284 - PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 08.09.2023 Database last updated on 03.09.2024 | |
Former | The patent has been granted Status updated on 30.09.2022 | ||
Former | Grant of patent is intended Status updated on 24.05.2022 | ||
Former | Examination is in progress Status updated on 15.02.2020 | ||
Former | Request for examination was made Status updated on 29.03.2019 | ||
Former | The international publication has been made Status updated on 29.12.2017 | ||
Former | unknown Status updated on 12.07.2017 | Most recent event Tooltip | 24.05.2024 | Lapse of the patent in a contracting state New state(s): IT | published on 26.06.2024 [2024/26] | Applicant(s) | For all designated states Mersana Therapeutics, Inc. 840 Memorial Drive Cambridge, MA 02139 / US | [2019/18] | Inventor(s) | 01 /
THOMAS, Joshua D. 83 Bacon Street Natick, Massachusetts 01760 / US | 02 /
YIN, Mao 50 Mount Vernon Street Needham, Massachusetts 02492 / US | 03 /
YURKOVETSKIY, Aleksandr 2 Old Farm Road Littleton, Massachusetts 01460 / US | 04 /
CONLON, Patrick R. 20 Eaton Street Wakefield, Massachusetts 01880 / US | 05 /
HILMY, Ahmed 64 Woburn Street Lexington, Massachusetts 02420 / US | 06 /
KELLEHER, Eugene W. 20 Sunnyside Avenue Wellesley, Massachusetts 02482 / US | 07 /
LOWINGER, Timothy B. 352 School Street Carlisle, Massachusetts 01741 / US | 08 /
STEVENSON, Cheri A. 81 Old Yankee Road Haverhill, Massachusetts 01832 / US | 09 /
TANG, Shuyi 1011 Halei Road Suite 306 Zhangjiang High-tech Park Pudong New District Shanghai / CN | [2019/18] | Representative(s) | Cooley (UK) LLP 22 Bishopsgate London EC2N 4BQ / GB | [2022/44] |
Former [2019/18] | Cooley (UK) LLP Dashwood 69 Old Broad Street London EC2M 1QS / GB | Application number, filing date | 17734623.6 | 22.06.2017 | [2019/18] | WO2017US38684 | Priority number, date | US201662354609P | 24.06.2016 Original published format: US 201662354609 P | US201762486750P | 18.04.2017 Original published format: US 201762486750 P | [2019/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017223275 | Date: | 28.12.2017 | Language: | EN | [2017/52] | Type: | A1 Application with search report | No.: | EP3475284 | Date: | 01.05.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.12.2017 takes the place of the publication of the European patent application. | [2019/18] | Type: | B1 Patent specification | No.: | EP3475284 | Date: | 02.11.2022 | Language: | EN | [2022/44] | Search report(s) | International search report - published on: | EP | 28.12.2017 | Classification | IPC: | C07D487/04, A61K31/5517, A61P35/00 | [2019/18] | CPC: |
C07D243/14 (EP,US);
A61K31/5517 (EP,US);
A61K47/59 (US);
A61K47/62 (US);
A61K47/68035 (EP,US);
A61K47/6855 (EP,US);
A61K47/6883 (EP,US);
A61P35/00 (EP);
C07D487/04 (EP,US);
C08L59/00 (US);
C12N15/111 (US);
C07C2523/44 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/18] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | PYRROLOBENZODIAZEPINE UND KONJUGATE DAVON | [2019/18] | English: | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF | [2019/18] | French: | PYRROLOBENZODIAZÉPINES ET CONJUGUÉS DE CELLES-CI | [2019/18] | Entry into regional phase | 23.01.2019 | National basic fee paid | 23.01.2019 | Designation fee(s) paid | 23.01.2019 | Examination fee paid | Examination procedure | 23.01.2019 | Examination requested [2019/18] | 23.01.2019 | Date on which the examining division has become responsible | 23.08.2019 | Amendment by applicant (claims and/or description) | 19.02.2020 | Despatch of a communication from the examining division (Time limit: M06) | 26.08.2020 | Reply to a communication from the examining division | 04.12.2020 | Despatch of a communication from the examining division (Time limit: M04) | 14.04.2021 | Reply to a communication from the examining division | 12.08.2021 | Despatch of a communication from the examining division (Time limit: M04) | 21.12.2021 | Reply to a communication from the examining division | 25.05.2022 | Communication of intention to grant the patent | 21.09.2022 | Fee for grant paid | 21.09.2022 | Fee for publishing/printing paid | 21.09.2022 | Receipt of the translation of the claim(s) | Opposition(s) | 03.08.2023 | No opposition filed within time limit [2023/41] | Fees paid | Renewal fee | 27.06.2019 | Renewal fee patent year 03 | 29.06.2020 | Renewal fee patent year 04 | 28.06.2021 | Renewal fee patent year 05 | 27.06.2022 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 02.11.2022 | AT | 02.11.2022 | CZ | 02.11.2022 | DK | 02.11.2022 | EE | 02.11.2022 | ES | 02.11.2022 | FI | 02.11.2022 | HR | 02.11.2022 | IT | 02.11.2022 | LT | 02.11.2022 | LV | 02.11.2022 | MC | 02.11.2022 | NL | 02.11.2022 | PL | 02.11.2022 | RO | 02.11.2022 | RS | 02.11.2022 | SE | 02.11.2022 | SI | 02.11.2022 | SK | 02.11.2022 | SM | 02.11.2022 | NO | 02.02.2023 | GR | 03.02.2023 | IS | 02.03.2023 | PT | 02.03.2023 | LU | 22.06.2023 | BE | 30.06.2023 | [2024/26] |
Former [2024/24] | AL | 02.11.2022 | |
AT | 02.11.2022 | ||
CZ | 02.11.2022 | ||
DK | 02.11.2022 | ||
EE | 02.11.2022 | ||
ES | 02.11.2022 | ||
FI | 02.11.2022 | ||
HR | 02.11.2022 | ||
LT | 02.11.2022 | ||
LV | 02.11.2022 | ||
MC | 02.11.2022 | ||
NL | 02.11.2022 | ||
PL | 02.11.2022 | ||
RO | 02.11.2022 | ||
RS | 02.11.2022 | ||
SE | 02.11.2022 | ||
SI | 02.11.2022 | ||
SK | 02.11.2022 | ||
SM | 02.11.2022 | ||
NO | 02.02.2023 | ||
GR | 03.02.2023 | ||
IS | 02.03.2023 | ||
PT | 02.03.2023 | ||
LU | 22.06.2023 | ||
BE | 30.06.2023 | ||
Former [2024/15] | AL | 02.11.2022 | |
AT | 02.11.2022 | ||
CZ | 02.11.2022 | ||
DK | 02.11.2022 | ||
EE | 02.11.2022 | ||
ES | 02.11.2022 | ||
FI | 02.11.2022 | ||
HR | 02.11.2022 | ||
LT | 02.11.2022 | ||
LV | 02.11.2022 | ||
MC | 02.11.2022 | ||
NL | 02.11.2022 | ||
PL | 02.11.2022 | ||
RO | 02.11.2022 | ||
RS | 02.11.2022 | ||
SE | 02.11.2022 | ||
SI | 02.11.2022 | ||
SK | 02.11.2022 | ||
SM | 02.11.2022 | ||
NO | 02.02.2023 | ||
GR | 03.02.2023 | ||
IS | 02.03.2023 | ||
PT | 02.03.2023 | ||
LU | 22.06.2023 | ||
Former [2024/09] | AL | 02.11.2022 | |
AT | 02.11.2022 | ||
CZ | 02.11.2022 | ||
DK | 02.11.2022 | ||
EE | 02.11.2022 | ||
ES | 02.11.2022 | ||
FI | 02.11.2022 | ||
HR | 02.11.2022 | ||
LT | 02.11.2022 | ||
LV | 02.11.2022 | ||
MC | 02.11.2022 | ||
NL | 02.11.2022 | ||
PL | 02.11.2022 | ||
RO | 02.11.2022 | ||
RS | 02.11.2022 | ||
SE | 02.11.2022 | ||
SI | 02.11.2022 | ||
SK | 02.11.2022 | ||
SM | 02.11.2022 | ||
NO | 02.02.2023 | ||
GR | 03.02.2023 | ||
IS | 02.03.2023 | ||
PT | 02.03.2023 | ||
Former [2023/51] | AL | 02.11.2022 | |
AT | 02.11.2022 | ||
CZ | 02.11.2022 | ||
DK | 02.11.2022 | ||
EE | 02.11.2022 | ||
ES | 02.11.2022 | ||
FI | 02.11.2022 | ||
HR | 02.11.2022 | ||
LT | 02.11.2022 | ||
LV | 02.11.2022 | ||
NL | 02.11.2022 | ||
PL | 02.11.2022 | ||
RO | 02.11.2022 | ||
RS | 02.11.2022 | ||
SE | 02.11.2022 | ||
SI | 02.11.2022 | ||
SK | 02.11.2022 | ||
SM | 02.11.2022 | ||
NO | 02.02.2023 | ||
GR | 03.02.2023 | ||
IS | 02.03.2023 | ||
PT | 02.03.2023 | ||
Former [2023/38] | AL | 02.11.2022 | |
AT | 02.11.2022 | ||
CZ | 02.11.2022 | ||
DK | 02.11.2022 | ||
EE | 02.11.2022 | ||
ES | 02.11.2022 | ||
FI | 02.11.2022 | ||
HR | 02.11.2022 | ||
LT | 02.11.2022 | ||
LV | 02.11.2022 | ||
NL | 02.11.2022 | ||
PL | 02.11.2022 | ||
RO | 02.11.2022 | ||
RS | 02.11.2022 | ||
SE | 02.11.2022 | ||
SK | 02.11.2022 | ||
SM | 02.11.2022 | ||
NO | 02.02.2023 | ||
GR | 03.02.2023 | ||
IS | 02.03.2023 | ||
PT | 02.03.2023 | ||
Former [2023/37] | AL | 02.11.2022 | |
AT | 02.11.2022 | ||
CZ | 02.11.2022 | ||
DK | 02.11.2022 | ||
EE | 02.11.2022 | ||
ES | 02.11.2022 | ||
FI | 02.11.2022 | ||
HR | 02.11.2022 | ||
LT | 02.11.2022 | ||
LV | 02.11.2022 | ||
NL | 02.11.2022 | ||
PL | 02.11.2022 | ||
RO | 02.11.2022 | ||
RS | 02.11.2022 | ||
SE | 02.11.2022 | ||
SM | 02.11.2022 | ||
NO | 02.02.2023 | ||
GR | 03.02.2023 | ||
IS | 02.03.2023 | ||
PT | 02.03.2023 | ||
Former [2023/35] | AT | 02.11.2022 | |
CZ | 02.11.2022 | ||
DK | 02.11.2022 | ||
EE | 02.11.2022 | ||
ES | 02.11.2022 | ||
FI | 02.11.2022 | ||
HR | 02.11.2022 | ||
LT | 02.11.2022 | ||
LV | 02.11.2022 | ||
NL | 02.11.2022 | ||
PL | 02.11.2022 | ||
RO | 02.11.2022 | ||
RS | 02.11.2022 | ||
SE | 02.11.2022 | ||
SM | 02.11.2022 | ||
NO | 02.02.2023 | ||
GR | 03.02.2023 | ||
IS | 02.03.2023 | ||
PT | 02.03.2023 | ||
Former [2023/34] | AT | 02.11.2022 | |
DK | 02.11.2022 | ||
EE | 02.11.2022 | ||
ES | 02.11.2022 | ||
FI | 02.11.2022 | ||
HR | 02.11.2022 | ||
LT | 02.11.2022 | ||
LV | 02.11.2022 | ||
NL | 02.11.2022 | ||
PL | 02.11.2022 | ||
RS | 02.11.2022 | ||
SE | 02.11.2022 | ||
SM | 02.11.2022 | ||
NO | 02.02.2023 | ||
GR | 03.02.2023 | ||
IS | 02.03.2023 | ||
PT | 02.03.2023 | ||
Former [2023/33] | AT | 02.11.2022 | |
DK | 02.11.2022 | ||
ES | 02.11.2022 | ||
FI | 02.11.2022 | ||
HR | 02.11.2022 | ||
LT | 02.11.2022 | ||
LV | 02.11.2022 | ||
NL | 02.11.2022 | ||
PL | 02.11.2022 | ||
RS | 02.11.2022 | ||
SE | 02.11.2022 | ||
SM | 02.11.2022 | ||
NO | 02.02.2023 | ||
GR | 03.02.2023 | ||
IS | 02.03.2023 | ||
PT | 02.03.2023 | ||
Former [2023/29] | AT | 02.11.2022 | |
ES | 02.11.2022 | ||
FI | 02.11.2022 | ||
HR | 02.11.2022 | ||
LT | 02.11.2022 | ||
LV | 02.11.2022 | ||
NL | 02.11.2022 | ||
PL | 02.11.2022 | ||
RS | 02.11.2022 | ||
SE | 02.11.2022 | ||
NO | 02.02.2023 | ||
GR | 03.02.2023 | ||
IS | 02.03.2023 | ||
PT | 02.03.2023 | ||
Former [2023/25] | AT | 02.11.2022 | |
ES | 02.11.2022 | ||
FI | 02.11.2022 | ||
HR | 02.11.2022 | ||
LT | 02.11.2022 | ||
LV | 02.11.2022 | ||
PL | 02.11.2022 | ||
RS | 02.11.2022 | ||
SE | 02.11.2022 | ||
NO | 02.02.2023 | ||
GR | 03.02.2023 | ||
IS | 02.03.2023 | ||
PT | 02.03.2023 | ||
Former [2023/23] | AT | 02.11.2022 | |
ES | 02.11.2022 | ||
FI | 02.11.2022 | ||
LT | 02.11.2022 | ||
LV | 02.11.2022 | ||
SE | 02.11.2022 | ||
NO | 02.02.2023 | ||
GR | 03.02.2023 | ||
PT | 02.03.2023 | ||
Former [2023/22] | AT | 02.11.2022 | |
ES | 02.11.2022 | ||
FI | 02.11.2022 | ||
LT | 02.11.2022 | ||
SE | 02.11.2022 | ||
NO | 02.02.2023 | ||
PT | 02.03.2023 | ||
Former [2023/20] | LT | 02.11.2022 | |
NO | 02.02.2023 | Cited in | International search | [A]WO2008099416 (COUNCIL SCIENT IND RES [IN], et al); | [X]WO2013164592 (UCL BUSINESS PLC [GB], et al); | [XPI]WO2017032983 (FEMTOGENIX LTD [GB]); | [XPI]WO2017051249 (LEGOCHEM BIOSCIENCES INC [KR]); | Examination | WO2013164593 | by applicant | US4309437 | US5583024 | US5674713 | US5700670 | US5763263 | US7303749 | WO2011013063 | WO2011130616 | WO2011130613 | WO2011130598 | WO2011128650 | WO2012128868 | WO2013041606 | WO2013055993 | WO2013055990 | WO2013053873 | WO2013053871 | WO2013055987 | WO2013164593 | WO2013177481 | WO2014011519 | WO2014011518 | WO2014022679 | WO2014057122 | WO2014057073 | WO2014057074 | WO2014096365 | WO2014096368 | WO2014130879 | WO2014140174 | WO2014174111 | US2015010440 | WO2015023355 | WO2015052535 | WO2015052534 | WO2015052321 | WO2015052322 | US2015133435 | WO2015095227 | WO2015095124 | WO2015159076 | US2016031887 | WO2016037644 | WO2016040723 | WO2016044560 | WO2016044396 |